|
|
General
|
| |
Clinical Use:
|
CA125 is identified as a 200 to 1000 kDa mucin-like glycoprotein and is a surface antigen associated with non-mucinous epithelial ovarian cancer. It is a useful tumour marker for evaluating therapy and monitoring disease status in patients under treatment for ovarian cancer. Post operatively the level of CA125 correlates with tumour bulk and is a prognostic indicator of clinical outcome. It has been reported that patients with levels exceeding 35 kU/L have the highest risk of clinical recurrence. |
| |
Availability:
|
Samples are tested Monday-Saturday. |
| |
Aliases/Synonyms:
| OMMA, |
| |
Code:
|
C125 |
| |
Handling Instructions (to laboratory):
|
Send sample chilled. |
| |
Hyperlink:
|
|
| |
Reference Interval:
|
<35 kU/L
|
Collection Requirements
|
| |
Container:
|
Serum Sep. Tube-SST (GOLD), |
| |
Sample Type:
|
See container |
| |
Minimum Collection Volume:
|
2mL |
| |
Collection Instructions:
|
|
Processing Requirements
|
| |
Alternate Containers:
|
|
|
|
|
Lithium Heparin-PST (GREEN) |
| |
Processing Instructions:
|
|
| |
Minimum Assay Volume:
|
250uL |
| |
Stability:
|
2 weeks chilled; 2 months frozen |
| |
Transport Instructions (to testing laboratory):
|
Send sample chilled. |
Testing Locations
|
| |
Performed at:
|
|
Section
|
Department
|
Site
|
Contact Phone
|
| Core |
Biochemistry |
Fiona Stanley Hospital |
6152 8140 |
| Core |
Biochemistry |
QEII Medical Centre |
6383 4093 |
|
Last Updated : 03-10-2020 08:08 |